Maple Allergy Clinic
Clinic • Brandyburgh, TX
Veeva ID: 001hco000716
FiltersTap to open
Snapshot
Engagement
Called 6w ago
Sales motion
5-90%
Net units this period · 48 prior
Top HCP here
—
No affiliated HCPs scored
Interactions (last 12 weeks)
8
-58% vs prior period
Reps engaged (last 12 weeks)
4
Last contact
43 days ago
Jul 24, 2026
Net units (last 12 weeks)
5
$9K net dollars · -89% vs prior period
Calls — weekly
13 most recent weeks for Maple Allergy Clinic
Net units — weekly
Signed units (sales − returns), 13 most recent weeks for Maple Allergy Clinic · last sale Jul 25, 2026
Top products
By units in last 12 weeks for Maple Allergy Clinic
| # | Product | NDC | Brand | Units | Net dollars |
|---|---|---|---|---|---|
| 1 | Lyseva 100mg Vial | 63459-1001-01 | Lyseva | 4 | $6K |
| 2 | Lyseva PFS 100mg | 63459-1002-01 | Lyseva | 2 | $3K |
Sales attribution
Which territory + rep this account's sales roll up to. Set in Veeva via account-territory assignments. The Primary row is the one dashboard sales aggregates use.
| Primary | Territory | Team role | Current Sales rep | Assignment |
|---|---|---|---|---|
| Primary | Rockies 28 ROC28 | MSL | Kevin Payne | Rule: geographic |
How primary is picked: when an account is assigned to multiple territories (Veeva supports this), Aimliticspicks one as primary for sales attribution using this priority — territories with an assigned Sales rep first, then team role (SAM > KAD > ALL), then manual-over-rule assignments, then alphabetical by territory name.
To change: edit the account-territory assignment in Veeva (or assign a Sales-typed user to the territory if no rep is shown). Changes flow into Aimlitics on the next pipeline refresh.
Reps who've called
By calls in last 12 weeks
| # | Rep | Title | Last call | Calls |
|---|---|---|---|---|
| 1 | Marcus Smith | Sales Representative | Jun 24, 2026 | 3 |
| 2 | Alexander Johnson | Sales Representative | Jul 24, 2026 | 2 |
| 3 | Kevin Payne | Sales Representative | Jul 17, 2026 | 2 |
| 4 | Sydney Reeves | Sales Representative | Jul 1, 2026 | 1 |